EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: Read More
| Price | 10.75p on 07-01-2026 at 12:45:05 |
|---|---|
| Change | -1.05p -8.9% |
| Buy | 11.50p |
| Sell | 10.00p |
| Last Trade: | Buy 344.00 at 11.04p |
| Day's Volume: | 102,452 |
| Last Close: | 11.80p |
| Open: | 11.50p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 10.75p - 11.50p |
| 52wk Range: | 5.25p - 11.90p |
| Market Capitalisation: | £660.20m |
| VWAP: | 11.49086p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 344 | 11.04p | Ordinary |
09:26:44 - 07-Jan-26 |
| Buy* | 50 | 11.04p | Ordinary |
09:16:34 - 07-Jan-26 |
| Buy* | 181 | 11.04p | Ordinary |
09:10:38 - 07-Jan-26 |
| Buy* | 77 | 10.8255p | Ordinary |
09:02:39 - 07-Jan-26 |
| Buy* | 2,000 | 11.345p | Ordinary |
08:02:22 - 07-Jan-26 |
| Unknown* | 2,000 | 11.345p | OTC Trade |
08:02:22 - 07-Jan-26 |
| Buy* | 17,002 | 11.50p | Ordinary |
08:01:00 - 07-Jan-26 |
| Buy* | 80,798 | 11.50p | Suspected BUY Trade |
08:00:25 - 07-Jan-26 |
| Buy* | 40,000 | 11.045p | Ordinary |
16:21:06 - 06-Jan-26 |
| Buy* | 2,661 | 11.045p | Ordinary |
15:07:43 - 06-Jan-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |
| 9th Dec 2025 7:00 am | RNS | Primary Safety Endpoint Met in PROTECT trial |
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |